摘要
近年来流行病学调查资料显示,我国的耐多药结核分枝杆菌形势日趋严峻,总耐药率为8.32%,其中初治涂阳肺结核为5.71%,高于世界卫生组织(WHO)估算的5.0%,复治涂阳肺结核为25.64%,接近WHO估算的26%,已成为全球耐多药结核分枝杆菌的高负担国之一。对此,有效地控制耐多药结核病的发生,关注结核病的管理和规范化治疗将成为推动医学领域革命性变化的动力。
The recent survey about the epidemiology showed that the situation ofthe multiple resistance ofthe M.tuberculosis was becoming more and more serious.The general resistance rate was 8.32%.Among it,the resistance rate of the smear positive cases treated first tuberculosis was 5.7%,it exceeded nearly 5% that estimated by WHO,and the resistance rate of the smear positive case retreatment TB was 25.64%,it exceeded nearly 26% that estimated by WHO.These led China to be one of the high-burden countries of the multiple resistance of the M.tuberculosis in the worldwide.Therefore,in order to control the happening of the MDR-TB effectively,paying attention to the management and norm of the tuberculosis would become the power to move forward the revolutionary change of the medical science.
出处
《基层医学论坛》
2012年第10期1321-1322,共2页
The Medical Forum
基金
2011年新都区第一批社会事业科技计划项目(201117)
关键词
结核分枝杆菌
耐多药
规范化治疗
控制策略
M.tuberculosis Multiple resistance Standardized treatment Control strategy
